Most SUMF1 variants identified in individuals with MSD are missense variants that likely permit residual enzyme activity, and it has been noted that all MSD patients have reduced but measurable levels of sulfatase activity (9). This evidence concerns the gene SUMF1 and mucosulfatidosis.